Table 5 Fluid therapy management and monitoring strategy
From: Observational study on fluid therapy management in surgical adult patients
ALL | Low-intermediate risk surgery & low risk patient | Low-intermediate risk surgery & high risk patient | High-very high risk surgery & low risk patient | High-very high risk surgery & high risk patient | N | |
|---|---|---|---|---|---|---|
N=6246 | N=3791 | N=928 | N=980 | N=547 | ||
Monitoring | ||||||
Non-invasive monitoring (NIBP, EGC, SpO2), N (%) | 6187 (99.1%) | 3757 (99.1%) | 917 (98.8%) | 968 (98.8%) | 545 (99.6%) | 6246 |
IBP, N (%) | 630 (10.1%) | 133 (3.52%) | 122 (13.2%) | 169 (17.3%) | 206 (38.0%) | 6215 |
CVP, N (%) | 243 (3.91%) | 40 (1.06%) | 41 (4.43%) | 61 (6.27%) | 101 (18.6%) | 6207 |
Diuresis control, N (%) | 1915 (30.9%) | 830 (22.0%) | 357 (38.6%) | 415 (42.7%) | 313 (57.4%) | 6207 |
Advanced haemodynamic monitoring, N (%) | 206 (3.32%) | 32 (0.85%) | 36 (3.90%) | 53 (5.42%) | 85 (15.6%) | 6213 |
Fluid therapy management in the intraoperative period | ||||||
Patients receiving additional fluids, N (%) | 6173 | |||||
No | 5778 (93.6%) | 3593 (96.0%) | 828 (90.4%) | 894 (92.1%) | 463 (85.3%) | |
By protocol | 93 (1.51%) | 14 (0.37%) | 20 (2.18%) | 22 (2.27%) | 37 (6.81%) | |
Without protocol | 302 (4.89%) | 136 (3.63%) | 68 (7.42%) | 55 (5.66%) | 43 (7.92%) | |
Fluid therapy management in the first 24 postoperative hours | ||||||
Patients receiving additional fluids, N (%) | 5865 | |||||
No | 5729 (97.7%) | 3580 (98.8%) | 841 (97.3%) | 884 (96.9%) | 424 (90.8%) | |
By protocol | 32 (0.55%) | 3 (0.08%) | 6 (0.69%) | 5 (0.55%) | 18 (3.85%) | |
Without protocol | 104 (1.77%) | 39 (1.08%) | 17 (1.97%) | 23 (2.52%) | 25 (5.35%) | |